The reported downregulation of SOCS3 in our study is in line with the Barclay et al. study which demonstrated the antiproliferative role of this gene via inhibition of STAT3 expression and suppression of STAT5 phosphorylation in breast cancer cells [17]. Here, STAT3 is linked to breast cancer.